Glioblastoma (GBM) is characterized by pronounced cell-state plasticity and functional heterogeneity, which drive therapeutic resistance, tumor recurrence, and disease evolution. Although these processes have traditionally been viewed through a predominantly genomic perspective, emerging evidence identifies endocrine s...
Jessica García-Sánchez, Alicia Cañas-Linares, P. García-López· Frontiers in Endocrinology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.